关注
Nicole K. Paulk, PhD
Nicole K. Paulk, PhD
CEO, Siren Biotechnology
在 sirenbiotechnology.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice
H Azuma, N Paulk, A Ranade, C Dorrell, M Al-Dhalimy, E Ellis, S Strom, ...
Nature Biotechnology 25 (8), 903-910, 2007
9112007
Promoterless gene targeting without nucleases ameliorates haemophilia B in mice
A Barzel, NK Paulk, Y Shi, Y Huang, K Chu, F Zhang, P Valdmanis, ...
Nature 517 (7534), 360-364, 2015
2842015
Bioengineered AAV capsids with combined high human liver transduction in vivo and unique humoral seroreactivity
NK Paulk, K Pekrun, E Zhu, S Nygaard, B Li, J Xu, K Chu, C Leborgne, ...
Molecular Therapy, 2017
1822017
Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo
NK Paulk, K Wursthorn, Z Wang, M Finegold, M Kay, M Grompe
Hepatology 51 (4), 1200-1208, 2010
1532010
Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase
F Puzzo, P Colella, MG Biferi, D Bali, NK Paulk, P Vidal, F Collaud, ...
Science Translational Medicine 9 (418), eaam6375, 2017
1232017
Ploidy reductions in murine fusion-derived hepatocytes
A Duncan, R Hickey, NK Paulk, A Culberson, S Olson, M Finegold, ...
PLoS Genetics 5 (2), e1000385, 2009
1232009
Methods matter: standard production platforms for recombinant AAV produce chemically and functionally distinct vectors
NG Rumachik, SA Malaker, N Poweleit, LH Maynard, CM Adams, RD Leib, ...
Molecular therapy Methods & clinical development 18, 98-118, 2020
1142020
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity.
IP Winters, SH Chiou, NK Paulk, CD McFarland, PV Lalgudi, RK Ma, L Lisowski ...
Nature Communications 8 (2053), 2017
1032017
Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition
A Taylor, A Preston, NK Paulk, H Sutherland, C Keenan, P Wilson, ...
Osteoarthritis and Cartilage 20 (8), 880-886, 2012
542012
Gene Therapy: It Is Time to Talk about High-Dose AAV: The deaths of two children with X-linked myotubular myopathy in the ASPIRO trial prompts a reexamination of vector safety
N Paulk
Genetic Engineering & Biotechnology News 40 (9), 14-16, 2020
432020
An orange calcium-modulated bioluminescent indicator for non-invasive activity imaging
Y Oh, Y Park, JH Cho, H Wu, NK Paulk, LX Liu, N Kim, MA Kay, JC Wu, ...
Nature chemical biology 15 (5), 433-436, 2019
422019
AAV-mediated gene targeting is significantly enhanced by transient inhibition of nonhomologous end joining or the proteasome in vivo
NK Paulk, LM Loza, MJ Finegold, M Grompe
Human Gene Therapy 23 (6), 658-665, 2012
412012
Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
MA Kay, NK Paulk
US Patent 10,385,320, 2019
372019
Novel Recombinant Adeno-Associated Virus Capsids with Enhanced Human Skeletal Muscle Tropism
MA Kay, NK Paulk
US Patent App. 15/367,734, 2016
37*2016
Bioengineered viral platform for intramuscular passive vaccine delivery to human skeletal muscle
NK Paulk, K Pekrun, GW Charville, K Maguire-Nguyen, MN Wosczyna, ...
Molecular Therapy Methods & Clinical Development 10, 144-155, 2018
302018
In vivo selection of transplanted hepatocytes by pharmacological inhibition of fumarylacetoacetate hydrolase in wild-type mice
NK Paulk, K Wursthorn, A Haft, C Pelz, G Clarke, AH Newell, SB Olson, ...
Molecular Therapy 20 (10), 1981-1987, 2012
192012
Photochemistry of iron in simulated crustal aerosols with dimethyl sulfide oxidation products
JM Key, N Paulk, AM Johansen
Environmental Science & Technology 42 (1), 133-139, 2007
192007
Fast-Seq: a simple method for rapid and inexpensive validation of packaged single-stranded adeno-associated viral genomes in academic settings
LH Maynard, O Smith, NP Tilmans, E Tham, S Hosseinzadeh, W Tan, ...
Human gene therapy methods 30 (6), 195-205, 2019
182019
Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences
PD Trivedi, C Yu, P Chaudhuri, EJ Johnson, T Caton, L Adamson, ...
Molecular Therapy-Methods & Clinical Development 24, 154-170, 2022
172022
VectorMOD: Method for bottom-up proteomic characterization of rAAV capsid post-translational modifications and vector impurities
NG Rumachik, SA Malaker, NK Paulk
Frontiers in Immunology 12, 657795, 2021
122021
系统目前无法执行此操作,请稍后再试。
文章 1–20